The aggressive cell-cycle phenotype III (actively cycling), strongly linked to a poor prognosis in our patient cohort, was much more highly represented in Her-2 subtype and triple negative tumours (hormone receptor-negative breast cancer) when compared with breast cancers of the luminal subtype. Here, ERBB2 is linked to breast carcinoma.